Homo sapiens Protein: ITK | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||||||||||||||
InnateDB Protein | IDBP-380839.4 | ||||||||||||||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||||||||||||||
Gene Symbol | ITK | ||||||||||||||||||||||||||||||
Protein Name | IL2-inducible T-cell kinase | ||||||||||||||||||||||||||||||
Synonyms | EMT; LPFS1; LYK; PSCTK2; | ||||||||||||||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||||||||||||||
Ensembl Protein | ENSP00000398655 | ||||||||||||||||||||||||||||||
InnateDB Gene | IDBG-55348 (ITK) | ||||||||||||||||||||||||||||||
Protein Structure | |||||||||||||||||||||||||||||||
UniProt Annotation | |||||||||||||||||||||||||||||||
Function | Tyrosine kinase that plays an essential role in regulation of the adaptive immune response. Regulates the development, function and differentiation of conventional T-cells and nonconventional NKT-cells. When antigen presenting cells (APC) activate T-cell receptor (TCR), a series of phosphorylation lead to the recruitment of ITK to the cell membrane, in the vicinity of the stimulated TCR receptor, where it is phosphorylated by LCK. Phosphorylation leads to ITK autophosphorylation and full activation. Once activated, phosphorylates PLCG1, leading to the activation of this lipase and subsequent cleavage of its substrates. In turn, the endoplasmic reticulum releases calcium in the cytoplasm and the nuclear activator of activated T-cells (NFAT) translocates into the nucleus to perform its transcriptional duty. Phosphorylates 2 essential adapter proteins: the linker for activation of T-cells/LAT protein and LCP2. Then, a large number of signaling molecules such as VAV1 are recruited and ultimately lead to lymphokine production, T-cell proliferation and differentiation. {ECO:0000269PubMed:12186560, ECO:0000269PubMed:12682224, ECO:0000269PubMed:21725281}. | ||||||||||||||||||||||||||||||
Subcellular Localization | Cytoplasm {ECO:0000269PubMed:17060314}. Note=Localizes in the vicinity of cell surface receptors in the plasma membrane after receptor stimulation. | ||||||||||||||||||||||||||||||
Disease Associations | Lymphoproliferative syndrome 1 (LPFS1) [MIM:613011]: A rare immunodeficiency characterized by extreme susceptibility to infection with Epstein-Barr virus (EBV). Inadequate immune response to EBV can have a fatal outcome. Clinical features include splenomegaly, lymphadenopathy, anemia, thrombocytopenia, pancytopenia, recurrent infections. There is an increased risk for lymphoma. {ECO:0000269PubMed:19425169}. Note=The disease is caused by mutations affecting the gene represented in this entry. | ||||||||||||||||||||||||||||||
Tissue Specificity | T-cell lines and natural killer cell lines. | ||||||||||||||||||||||||||||||
Comments | |||||||||||||||||||||||||||||||
Interactions | |||||||||||||||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 45 experimentally validated interaction(s) in this database.
They are also associated with 7 interaction(s) predicted by orthology.
|
||||||||||||||||||||||||||||||
Gene Ontology | |||||||||||||||||||||||||||||||
Molecular Function |
|
||||||||||||||||||||||||||||||
Biological Process |
|
||||||||||||||||||||||||||||||
Cellular Component |
|
||||||||||||||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||||||||||||||
PDB ID | |||||||||||||||||||||||||||||||
InterPro |
IPR000719
Protein kinase domain IPR000980 SH2 domain IPR001245 Serine-threonine/tyrosine-protein kinase catalytic domain IPR001452 SH3 domain IPR001562 Zinc finger, Btk motif IPR001849 Pleckstrin homology domain IPR002290 Serine/threonine/dual specificity protein kinase, catalytic domain IPR011009 Protein kinase-like domain IPR011511 Variant SH3 domain IPR020635 Tyrosine-protein kinase, catalytic domain |
||||||||||||||||||||||||||||||
PFAM |
PF00069
PF00017 PF14633 PF07714 PF00018 PF14604 PF00779 PF00169 PF07653 |
||||||||||||||||||||||||||||||
PRINTS |
PR00401
PR00109 PR00452 PR00402 |
||||||||||||||||||||||||||||||
PIRSF | |||||||||||||||||||||||||||||||
SMART |
SM00252
SM00326 SM00107 SM00233 SM00220 SM00219 |
||||||||||||||||||||||||||||||
TIGRFAMs | |||||||||||||||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||||||||||||||
Modification | |||||||||||||||||||||||||||||||
Cross-References | |||||||||||||||||||||||||||||||
SwissProt | Q08881 | ||||||||||||||||||||||||||||||
PhosphoSite | PhosphoSite-Q08881 | ||||||||||||||||||||||||||||||
TrEMBL | Q7Z318 | ||||||||||||||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||||||||||||||
Entrez Gene | 3702 | ||||||||||||||||||||||||||||||
UniGene | Hs.558348 | ||||||||||||||||||||||||||||||
RefSeq | NP_005537 | ||||||||||||||||||||||||||||||
HUGO | HGNC:6171 | ||||||||||||||||||||||||||||||
OMIM | 186973 | ||||||||||||||||||||||||||||||
CCDS | CCDS4336 | ||||||||||||||||||||||||||||||
HPRD | 01746 | ||||||||||||||||||||||||||||||
IMGT | |||||||||||||||||||||||||||||||
EMBL | AC010609 AK312846 BC109077 BC109078 BX538196 CH471062 D13720 L10717 S65186 | ||||||||||||||||||||||||||||||
GenPept | AAA36748 AAB28072 AAI09078 AAI09079 BAA02873 BAG35699 CAD98063 EAW61608 | ||||||||||||||||||||||||||||||